In Australia, more than 40,000 people are imprisoned every day. More than half of these people experience drug addiction, ...
Despite not differentiating itself from placebo, the Texas-based company said it plans to push pilavapadin into Phase III ...
Widespread access to opioid agonist treatment (OAT) can reduce the risk of suicide by 35% among people with opioid use ...
In February, the Smithtown Town Board approved the formation of the Opioid and Addiction Task Force. The group will work with ...
The leader of the nonprofit Project Opioid says steps County has taken are working, in light of the number of deaths nearly a ...
A new opioid-free pain medication was approved by the U.S. Food and Drug Administration (FDA) on Thursday, marking a non-addictive alternative for patients. Journavx (suzetrigine), made by Vertex ...
The FDA has approved label changes for once-monthly Sublocade, helping to reduce possible barriers to treatment initiation ...
7d
WRIC Richmond on MSNFDA approves first opioid-free painkiller in over two decadesThe U.S. Food and Drug Administration (FDA) has approved Journavx, the first opioid-free prescription drug for moderate to ...
KTLA-TV Los Angeles on MSN4d
FDA approves new opioid-free painkillerNeurosurgeon and scientist Dr. Jandial joined us to discuss a major breakthrough in pain medication recently approved by the ...
Feb. 25, 2025 – The FDA has approved a new treatment plan for a long-acting injection, making it easier for people with moderate to severe opioid use disorder (OUD) to start and keep up with ...
Ice rinks and toy robots: an investigation finds some questionable uses for money from the opioid settlement fund that was ...
On January 30, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results